Cyclerion Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 84.55 K | $129.80 K | 95.26% | 2.01% |
| CITADEL ADVISORS LLC | 05/15/2026 | 18.26 K | $28.03 K | 100.00% | 0.43% |
| BLACKROCK, INC. | 05/13/2026 | 16.80 K | $26.04 K | 0.00% | 0.40% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 16.14 K | $24.77 K | 100.00% | 0.38% |
| KOVACK ADVISORS, INC. | 05/13/2026 | 10.00 K | $15.50 K | 100.00% | 0.24% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 7.35 K | $11.29 K | 100.00% | 0.17% |
| FMR LLC | 05/15/2026 | 4.74 K | $7.28 K | 0.00% | 0.11% |
| UBS GROUP AG | 05/05/2026 | 3.39 K | $5.26 K | 801.86% | 0.08% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 192 | $295 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 130 | $201 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 100 | $155 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 04/15/2026 | 100 | $155 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 89 | $137 | -98.92% | 0.00% |
| WHI TRUST CO LLC | 04/24/2026 | 72 | $112 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 5 | $8 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 4 | $6 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SIREN, L.L.C. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Cyclerion Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Cyclerion Therapeutics Inc. The most heavily invested institutionals were:
MORGAN STANLEY: 0
Kovack Advisors, Inc.: 0
MAI Capital Management: 0
CITIGROUP INC: 0
Caitong International Asset Management Co., Ltd: 0
TWO SIGMA ADVISERS, LP: 28,300
3.85% of Cyclerion Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 652.18 K shares in the last 24 months. This purchase volume represents approximately $971.75 K in transactions.